2012 Aarkstore.com || Astellas Pharma Inc. – Product Pipeline Review – 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Astellas Pharma Inc. – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Market Direct’s pharmaceuticals report, “Astellas Pharma Inc. - Product
Pipeline Review - 2012” provides data on the Astellas Pharma Inc.’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Astellas Pharma Inc.’s corporate website, SEC filings,
investor presentations and featured press releases, both from Astellas Pharma Inc.
and industry-specific third party sources, put together by Global Markets Direct’s
team.
Scope
- Astellas Pharma Inc. - Brief Astellas Pharma Inc. overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Astellas Pharma Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development,
including the combination treatment modalities, across the globe.
Table of contents:

2. List of Tables 11
List of Figures 14
Astellas Pharma Inc. Snapshot 15
Astellas Pharma Inc. Overview 15
Key Information 15
Key Facts 15
Astellas Pharma Inc. – Research and Development Overview 16
Key Therapeutic Areas 16
Astellas Pharma Inc. – Pipeline Review 22
Pipeline Products by Stage of Development 22
Pipeline Products – Monotherapy 23
Pipeline Products – Combination Treatment Modalities 24
Astellas Pharma Inc. – Pipeline Products Glance 25
Astellas Pharma Inc. – Late Stage Pipeline 25
Registration Filed Products/Combination Treatment Modalities 25
Phase III Products/Combination Treatment Modalities 26
Astellas Pharma Inc. Clinical Stage Pipeline Products 28
Phase II Products/Combination Treatment Modalities 28
Phase I Products/Combination Treatment Modalities 30
Astellas Pharma Inc. – Early Stage Pipeline Products 31
Pre-Clinical Products/Combination Treatment Modalities 31
Astellas Pharma Inc. – Drug Profiles 32
Advagraf + Mycophenolate Mofetil 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Advagraf + Mycophenolate Mofetil + Methylprednisolone 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
Advagraf + Mycophenolate Mofetil + Basiliximab 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
AGS-16M8F 37
Product Description 37

3. Mechanism of Action 37
R&D Progress 37
AGS-1C4D4 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
AGS-1C4D4 + Gemcitabine 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
YM155 + Docetaxel 87
Product Description 87
Mechanism of Action 87
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Ardea Biosciences, Inc. – Product Pipeline Review – 2012
Astellas Pharma Inc. – Product Pipeline Review – 2012
Bayer AG – Product Pipeline Review – 2012

4. BioLineRx, Ltd. – Product Pipeline Review – 2012
Cytokinetics, Incorporated – Product Pipeline Review – 2012
Meda AB – Product Pipeline Review – 2012
Medivir AB – Product Pipeline Review – 2012
Nektar Therapeutics – Product Pipeline Review – 2012
Novo Nordisk A/S – Product Pipeline Review – 2012
SciClone Pharmaceuticals, Inc. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com